Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05273398 · ClinicalTrials.gov registry record · Phase 4
Effects of Diazepam on RNS Detections
A Phase 4 study, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 4
- Development phase
- 4
- Enrollment target
NCT05273398 is a Phase 4 study that has completed, run by University of Cincinnati. The registered enrollment target is 4 participants.
The verdict
NCT05273398, a Phase 4 study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 4 participants
- Enrollment target
Study Summary
To assess the magnitude and duration of reduction in RNS recorded Detections and Long Episodes following intranasal administration of Valtoco®. All participants will have been implanted and treated with an RNS system for clinical purposes and regularly upload Detection and Long Episode data on a regular basis as part of regular clinical treatment. Participants will come to the clinic and be administered a single dose of Valtoco® via nasal spray. RNS recorded Detections and Long Episodes before and after Valtoco® administration will be compared. This is a pilot study, so all outcomes are exploratory.
Interventions
- DRUG nasal diazepam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2022-11-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05273398
The ClinicalTrials.gov registry entry for NCT05273398 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which nasal diazepam is the first listed.
NCT05273398 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05273398 about?
NCT05273398 is a clinical study titled "Effects of Diazepam on RNS Detections". To assess the magnitude and duration of reduction in RNS recorded Detections and Long Episodes following intranasal administration of Valtoco®. All participants will have been implanted and treated with an RNS system for clinical purposes and regularly upload Detection and Long Episode data on a reg...
What is the current status of trial NCT05273398?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 4 participants. The study started on 2022-03-01. Estimated completion is 2022-11-10.
What interventions are being tested in trial NCT05273398?
The interventions under investigation include: nasal diazepam (DRUG).
Who is sponsoring clinical trial NCT05273398?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.